New Drug to Help Treat Spinal Muscular Atrophy in Infants

The new drug Nusinersen may have a positive impact on the lives of infants with a severe form of spinal muscular atrophy (SMA) finds a new study. Babies with this debilitating and deadly disease are usually destined to have a short lifespan and limited motor function.
Email bookmark
Font : A-A+

Related Links